Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Impax Laboratories patents

List of Impax Laboratories patents

List of Pulse Secure patents

List of CROSSROADS SYSTEMS patents

List of Kip (company) patents

List of companies in Trind Ventures's investment portfolio

List of companies in Kaiser Permanente Ventures's investment portfolio

Patents where

Current Assignee

Name

is

Impax Laboratories

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10973769 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof	Patent 10973769 was granted and assigned to Impax Laboratories on April, 2021 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	10973769	April 13, 2021
	‌ US Patent 8377474 Controlled release formulations of levodopa and uses thereof	Patent 8377474 was granted and assigned to Impax Laboratories on February, 2013 by the United States Patent and Trademark Office.		Impax Laboratories		United States Patent and Trademark Office	8377474	February 19, 2013
	‌ US Patent 12128141 Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof	Patent 12128141 was granted and assigned to Impax Laboratories on October, 2024 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	12128141	October 29, 2024
	‌ US Patent 10987313 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof	Patent 10987313 was granted and assigned to Impax Laboratories on April, 2021 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	10987313	April 27, 2021
	‌ US Patent 10292935 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof	Patent 10292935 was granted and assigned to Impax Laboratories on May, 2019 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	10292935	May 21, 2019
	‌ US Patent 10098845 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof	Patent 10098845 was granted and assigned to Impax Laboratories on October, 2018 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	10098845	October 16, 2018
	‌ US Patent 8454998 Controlled release formulations of levodopa and uses thereof	Patent 8454998 was granted and assigned to Impax Laboratories on June, 2013 by the United States Patent and Trademark Office.		Impax Laboratories		United States Patent and Trademark Office	8454998	June 4, 2013
	‌ US Patent 7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms	Patent 7094427 was granted and assigned to Impax Laboratories on August, 2006 by the United States Patent and Trademark Office.		Impax Laboratories		United States Patent and Trademark Office	7094427	August 22, 2006
	‌ US Patent 10688058 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof	Patent 10688058 was granted and assigned to Impax Laboratories on June, 2020 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	10688058	June 23, 2020
	‌ US Patent 9463246 Controlled release formulations of levodopa and uses thereof	Patent 9463246 was granted and assigned to Impax Laboratories on October, 2016 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	9463246	October 11, 2016
	‌ US Patent 9901640 Controlled release formulations of levodopa and uses thereof	Patent 9901640 was granted and assigned to Impax Laboratories on February, 2018 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	9901640	February 27, 2018
	‌ US Patent 9089608 Controlled release formulations of levodopa and uses thereof	Patent 9089608 was granted and assigned to Impax Laboratories on July, 2015 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	9089608	July 28, 2015
	‌ US Patent 8007827 Pharmaceutical dosage forms having immediate release and/or controlled release properties	Patent 8007827 was granted and assigned to Impax Laboratories on August, 2011 by the United States Patent and Trademark Office.		Impax Laboratories		United States Patent and Trademark Office	8007827	August 30, 2011
	‌ US Patent 9089607 Controlled release formulations of levodopa and uses thereof	Patent 9089607 was granted and assigned to Impax Laboratories on July, 2015 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	9089607	July 28, 2015
	‌ US Patent 9533046 Controlled release formulations of levodopa and uses thereof	Patent 9533046 was granted and assigned to Impax Laboratories on January, 2017 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	9533046	January 3, 2017
	‌ US Patent 8557283 Controlled release formulations of levodopa and uses thereof	Patent 8557283 was granted and assigned to Impax Laboratories on October, 2013 by the United States Patent and Trademark Office.		Impax Laboratories		United States Patent and Trademark Office	8557283	October 15, 2013
	‌ US Patent 12064521 Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof	Patent 12064521 was granted and assigned to Impax Laboratories on August, 2024 by the United States Patent and Trademark Office.	Impax Laboratories	Impax Laboratories		United States Patent and Trademark Office	12064521	August 20, 2024

17 results

0 selected

17 results

0 selected